Doctorglasses Chain Co.,Ltd. (SHE:300622)
China · Delayed Price · Currency is CNY 14.35
+0.06 (0.42%)
Sep 14, 2026, 3:04 PM CST
Doctorglasses Chain Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,578 | 7,077 | 8,730 | 3,400 | 3,527 | 3,918 | |
Market Cap Growth | -40.95% | -18.93% | 156.76% | -3.60% | -9.98% | 65.90% |
Enterprise Value | 4,183 | 6,832 | 8,756 | 3,390 | 3,526 | 3,678 |
Last Close Price | 14.35 | 21.71 | 26.72 | 10.08 | 10.37 | 11.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 26.35 | 47.62 | 84.24 | 26.55 | 46.52 | 41.34 |
Forward PE | - | 51.44 | 61.30 | 22.84 | 35.19 | 29.10 |
PS Ratio | 3.22 | 5.20 | 7.26 | 2.89 | 3.67 | 4.42 |
PB Ratio | 4.84 | 7.67 | 11.32 | 4.19 | 5.09 | 5.89 |
P/TBV Ratio | 4.96 | 7.86 | 11.67 | 4.51 | 5.21 | 6.04 |
P/FCF Ratio | 13.28 | 25.62 | 34.99 | 13.11 | 19.36 | 22.94 |
P/OCF Ratio | 12.50 | 23.83 | 31.69 | 12.10 | 16.92 | 18.28 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.94 | 5.02 | 7.28 | 2.88 | 3.66 | 4.14 |
EV/EBITDA Ratio | 15.57 | 37.52 | 59.32 | 19.68 | 36.03 | 29.30 |
EV/EBIT Ratio | 20.88 | 38.89 | 65.91 | 21.41 | 40.40 | 31.63 |
EV/FCF Ratio | 12.14 | 24.73 | 35.09 | 13.07 | 19.36 | 21.53 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.57 | 0.20 | 0.34 | 0.20 | 0.25 | 0.31 |
Debt / EBITDA Ratio | 1.99 | 0.61 | 0.96 | 0.55 | 0.75 | 0.81 |
Debt / FCF Ratio | 1.55 | 0.67 | 1.04 | 0.63 | 0.96 | 1.20 |
Net Debt / Equity Ratio | -0.44 | -0.43 | -0.09 | -0.12 | -0.16 | -0.12 |
Net Debt / EBITDA Ratio | -1.97 | -2.18 | -0.46 | -0.55 | -1.14 | -0.65 |
Net Debt / FCF Ratio | -1.20 | -1.44 | -0.27 | -0.36 | -0.61 | -0.47 |
Asset Turnover | 0.92 | 1.04 | 1.01 | 1.12 | 0.98 | 1.03 |
Inventory Turnover | 2.17 | 2.83 | 2.61 | 2.63 | 2.54 | 2.79 |
Quick Ratio | 2.52 | 1.97 | 1.20 | 1.75 | 1.95 | 1.77 |
Current Ratio | 3.21 | 2.88 | 2.37 | 2.70 | 2.97 | 2.53 |
Return on Equity (ROE) | 20.50% | 18.15% | 12.80% | 17.50% | 10.95% | 14.77% |
Return on Assets (ROA) | 8.14% | 8.41% | 6.99% | 9.43% | 5.55% | 8.42% |
Return on Invested Capital (ROIC) | 30.71% | 22.90% | 14.68% | 19.55% | 12.00% | 22.53% |
Return on Capital Employed (ROCE) | 14.40% | 17.70% | 15.20% | 17.40% | 11.20% | 15.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 3.84% | 2.10% | 1.19% | 3.77% | 2.15% | 2.42% |
FCF Yield | 7.53% | 3.90% | 2.86% | 7.63% | 5.16% | 4.36% |
Dividend Yield | 12.18% | 8.88% | 0.56% | 3.27% | 1.59% | 2.42% |
Payout Ratio | 38.05% | 17.99% | 141.94% | 47.08% | 125.61% | 71.04% |
Buyback Yield / Dilution | -2.94% | -1.49% | -0.13% | -0.46% | 0.04% | -2.15% |
Total Shareholder Return | 9.24% | 7.39% | 0.43% | 2.81% | 1.63% | 0.27% |